46 Publications (Page 1 of 2)
2024
Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention
⋅Anderson, Wesley L and Kreutz, Rolf P
The American Journal of Cardiology, vol. 217, pp. 35-38, Apr 15, 2024. | Journal Article
2020
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Mshelbwala, Fakilahyel S⋅Hugenberg, Daniel W and Kreutz, Rolf P
Clinical pharmacology : advances and applications, vol. 12, pp. 41, 2020-00-00. | Journal Article
Intensified P2Y12 inhibition for high-on treatment platelet reactivity
Mshelbwala, Fakilahyel S⋅Hugenberg, Daniel W and Kreutz, Rolf P
Journal of thrombosis and thrombolysis, 2020-Mar-09. | Journal Article
2019
Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants
Kanuri, Sri H and Kreutz, Rolf P
Journal of personalized medicine, vol. 9, (no. 1), pp. 7, 2019-Jan-17. | Journal Article
TO INTERVENE OR NOT: A CASE OF MULTI-VESSEL SPONTANEOUS CORONARY ARTERY DISSECTION
Robinson, Eric and Kreutz, Rolf
Journal of the American College of Cardiology, vol. 73, (no. 9), pp. 2432, 2019-03-12. | Journal Article
2018
Abstract 098: Next Generation MicroRNA Sequencing to Identify Coronary Artery Disease Patients at Risk of Recurrent Myocardial InfarctionKanuri, Sri Harsha⋅Kanuri, Sri Harsha⋅Kanuri, Sri Harsha⋅Kanuri, Sri Harsha⋅Ipe, Joseph⋅Ipe, Joseph⋅Ipe, Joseph⋅Ipe, Joseph⋅Kassab, Kameel⋅Kassab, Kameel⋅Kassab, Kameel⋅Kassab, Kameel⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Edenberg, Howard J⋅Edenberg, Howard J⋅Edenberg, Howard J⋅Edenberg, Howard J⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Gao, Hongyu⋅Gao, Hongyu⋅Gao, Hongyu⋅Gao, Hongyu⋅Kreutz, Rolf Peter⋅Kreutz, Rolf Peter⋅Kreutz, Rolf Peter and Kreutz, Rolf PeterArteriosclerosis, Thrombosis, and Vascular Biology, vol. 38, (no. Suppl_1), 2018-05-00.
| Journal Article
Abstract 12336: Nitric Oxide Synthase-3 G894T Polymorphism and Regadenoson Myocardial Perfusion ImagingKreutz, Rolf⋅Kreutz, Rolf⋅Kreutz, Rolf⋅Philips, Santosh⋅Philips, Santosh⋅Philips, Santosh⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Mastouri, Ronald⋅Mastouri, Ronald⋅Mastouri, Ronald⋅Skaar, Todd⋅Skaar, Todd and Skaar, ToddCirculation, vol. 138, (no. Suppl_1 Suppl 1), pp. A12336, 2018-November-6.
| Journal Article
A comprehensive review and meta-analysis of risk factors for statin-induced myopathyNguyen, Khoa⋅Nguyen, Khoa A⋅Nguyen, Khoa⋅Nguyen, K.A.⋅Li, Lang⋅Li, Lang⋅Li, L.⋅Lang, Li⋅Lu, Deshun⋅Lu, Deshun⋅Lu, Deshun⋅Lu, D.⋅Yazdanparast, Aida⋅Yazdanparast, Aida⋅Yazdanparast, A.⋅Yazdanparast, Aida⋅Wang, Lei⋅Wang, Lei⋅Wang, L.⋅Wang, Lei⋅Kreutz, Rolf⋅Kreutz, Rolf⋅Kreutz, R.P.⋅Kreutz, Rolf P⋅Whipple, Elizabeth C⋅Whipple, Elizabeth⋅Whipple, Elizabeth⋅Whipple, E.C.⋅Schleyer, T.K.⋅Schleyer, Titus K⋅Schleyer, Titus and Schleyer, TitusEuropean Journal of Clinical Pharmacology, vol. 74, (no. 9), pp. 1109, 20180900.
| Journal Article
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.
Maatman, Benjamin T⋅Maatman, Benjamin T⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Kreutz, Rolf P and Kreutz, Rolf P
Journal of diabetes research, vol. 2018, pp. 4543065, 2018. | Journal Article
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCavallari, Larisa H⋅LH, Cavallari⋅Cavallari, Larisa H⋅Cavallari, L.H.⋅Cavallari, LH⋅Cavallari, L. H.⋅Cavallari, Larisa H⋅Cavallari, Larisa H⋅Cavallari, L.H.⋅Cavallari, L. H.⋅LH, Cavallari⋅Cavallari, L.H.⋅Lee, C. R.⋅Lee, Craig R⋅Lee, C.R.⋅Lee, Craig R⋅CR, Lee⋅Lee, Craig R⋅Lee, C.R.⋅Lee, Craig R⋅Lee, C.R.⋅CR, Lee⋅Lee, C. R.⋅Lee, CR⋅Lee, Yee Ming⋅Beitelshees, Amber L⋅Beitelshees, A. L.⋅Beitelshees, A. L.⋅Beitelshees, AL⋅AL, Beitelshees⋅Beitelshees, Amber L⋅Beitelshees, Amber L⋅Beitelshees, A.L.⋅Beitelshees, A.L.⋅AL, Beitelshees⋅Beitelshees, A.L.⋅Beitelshees, Amber L⋅RM, Cooper-DeHoff⋅Cooper-DeHoff, Rhonda M⋅Cooper-DeHoff, Rhonda M⋅RM, Cooper-DeHoff⋅Cooper-DeHoff, R. M.⋅Cooper-DeHoff, R.M.⋅Cooper-DeHoff, Rhonda M⋅Cooper-DeHoff, R. M.⋅Cooper-DeHoff, Rhonda M⋅Cooper-DeHoff, R.M.⋅Cooper-DeHoff, R.M.⋅Cooper-DeHoff, RM⋅JD, Duarte⋅Duarte, Julio D⋅Duarte, Julio D⋅Duarte, J.D.⋅JD, Duarte⋅Duarte, J. D.⋅Duarte, Julio D⋅Duarte, J.D.⋅Duarte, J.D.⋅Duarte, J. D.⋅Duarte, JD⋅Duarte, Julio D⋅Voora, D.⋅Voora, Deepak⋅Voora, D.⋅Voora, D⋅D, Voora⋅Voora, D.⋅Voora, Deepak⋅Voora, D.⋅Voora, Deepak⋅Voora, Deepak⋅D, Voora⋅Voora, D.⋅Kimmel, Stephen E⋅Kimmel, SE⋅Kimmel, Stephen E⋅Kimmel, Stephen E⋅Kimmel, S.E.⋅SE, Kimmel⋅SE, Kimmel⋅Kimmel, S. E.⋅Kimmel, Stephen E⋅Kimmel, S. E.⋅Kimmel, S.E.⋅Kimmel, S.E.⋅McDonough, C.W.⋅McDonough, Caitrin W⋅McDonough, C.W.⋅McDonough, C. W.⋅McDonough, Caitrin W⋅McDonough, C. W.⋅CW, McDonough⋅Mc Donough, C.W.⋅CW, McDonough⋅McDonough, Caitrin W⋅McDonough, Caitrin W⋅McDonough, CW⋅Gong, Y⋅Gong, Y.⋅Y, Gong⋅Gong, Yan⋅Gong, Y.⋅Gong, Y.⋅Gong, Y.⋅Gong, Yan⋅Gong, Y.⋅Y, Gong⋅Gong, Yan⋅Gong, Yan⋅CV, Dave⋅Dave, C.V.⋅Dave, CV⋅Dave, C. V.⋅CV, Dave⋅Dave, Chintan V⋅Dave, C. V.⋅Dave, C.V.⋅Dave, Chintan V⋅Dave, Chintan V⋅Dave, C.V.⋅Dave, Chintan V⋅Pratt, Victoria M⋅Pratt, Victoria M⋅VM, Pratt⋅Pratt, V. M.⋅Pratt, Victoria M⋅Pratt, V.M.⋅Pratt, VM⋅Pratt, V.M.⋅VM, Pratt⋅Pratt, V. M.⋅Pratt, Victoria M⋅Pratt, V.M.⋅Alestock, T. D.⋅Alestock, TD⋅Alestock, T.D.⋅Alestock, T. D.⋅Alestock, Tameka D⋅TD, Alestock⋅Alestock, T.D.⋅Alestock, Tameka D⋅Alestock, Tameka D⋅TD, Alestock⋅Alestock, T.D.⋅Alestock, Tameka D⋅Anderson, R. David⋅Anderson, R. D.⋅Anderson, R.D.⋅Network, IGNITE⋅Anderson, R.D.⋅Anderson, R. David⋅Anderson, R. D.⋅Anderson, RD⋅Network, IGNITE⋅Anderson, R. David⋅Anderson, R. David⋅Anderson, R.D.⋅Alsip, J.⋅Alsip, Jorge⋅Alsip, J⋅Alsip, J.⋅Alsip, J.⋅Alsip, Jorge⋅Alsip, Jorge⋅Alsip, J.⋅Alsip, Jorge⋅Alsip, J.⋅Ardati, A.K.⋅Ardati, Amer K⋅Ardati, Amer K⋅Ardati, AK⋅Ardati, A. K.⋅Ardati, Amer K⋅Ardati, A.K.⋅Ardati, A.K.⋅Ardati, A. K.⋅Ardati, Amer K⋅Brott, B.C.⋅Brott, BC⋅Brott, Brigitta C⋅Brott, B.C.⋅Brott, B. C.⋅Brott, Brigitta C⋅Brott, B. C.⋅Brott, Brigitta C⋅Brott, Brigitta C⋅Brott, B.C.⋅Brown, Lawrence⋅Brown, L⋅Brown, Lawrence⋅Brown, L.⋅Brown, Lawrence⋅Brown, L.⋅Brown, L.⋅Brown, L.⋅Brown, Lawrence⋅Brown, L.⋅Chumnumwat, S.⋅Chumnumwat, Supatat⋅Chumnumwat, S⋅Chumnumwat, Supatat⋅Chumnumwat, S.⋅Chumnumwat, Supatat⋅Chumnumwat, S.⋅Chumnumwat, S.⋅Chumnumwat, S.⋅Chumnumwat, Supatat⋅Clare-Salzler, M. J.⋅Clare-Salzler, M. J.⋅Clare-Salzler, MJ⋅Clare-Salzler, Michael J⋅Clare-Salzler, Michael J⋅Clare-Salzler, Michael J⋅Clare-Salzler, M.J.⋅Clare-Salzler, Michael J⋅Clare-Salzler, M.J.⋅Clare-Salzler, M.J.⋅Coons, James C⋅Coons, J.C.⋅Coons, J.C.⋅Coons, JC⋅Coons, J.C.⋅Coons, J. C.⋅Coons, James C⋅Coons, J. C.⋅Coons, James C⋅Coons, James C⋅Denny, JC⋅Denny, J.C.⋅Denny, Joshua C⋅Denny, Joshua C⋅Denny, J. C.⋅Denny, J.C.⋅Denny, Joshua C⋅Denny, J.C.⋅Denny, Joshua C⋅Denny, J. C.⋅Dillon, Chrisly⋅Dillon, Chrisly⋅Dillon, Chrisly⋅Dillon, C.⋅Dillon, Chrisly⋅Dillon, C.⋅Dillon, C.⋅Dillon, C⋅Dillon, C.⋅Dillon, C.⋅Elsey, A.R.⋅Elsey, Amanda R⋅Elsey, A.R.⋅Elsey, A. R.⋅Elsey, A.R.⋅Elsey, AR⋅Elsey, Amanda R⋅Elsey, Amanda R⋅Elsey, Amanda R⋅Elsey, A. R.⋅Hamadeh, Issam S⋅Hamadeh, Issam S⋅Hamadeh, I.S.⋅Hamadeh, Issam S⋅Hamadeh, I. S.⋅Hamadeh, IS⋅Hamadeh, I.S.⋅Hamadeh, Issam S⋅Hamadeh, I. S.⋅Hamadeh, I.S.⋅Harada, S.⋅Harada, S.⋅Harada, S.⋅Harada, Shuko⋅Harada, S.⋅Harada, Shuko⋅Harada, Shuko⋅Harada, Shuko⋅Harada, S⋅Harada, S.⋅Hillegass, W. B.⋅Hillegass, William B⋅Hillegass, W.B.⋅Hillegass, WB⋅Hillegass, William B⋅Hillegass, W.B.⋅Hillegass, William B⋅Hillegass, W. B.⋅Hillegass, W.B.⋅Hillegass, William B⋅Hines, Lindsay⋅Hines, L.⋅Hines, L.⋅Hines, Lindsay⋅Hines, L.⋅Hines, L.⋅Hines, L⋅Hines, L.⋅Hines, Lindsay⋅Hines, Lindsay⋅Horenstein, R. B.⋅Horenstein, Richard B⋅Horenstein, R.B.⋅Horenstein, Richard B⋅Horenstein, Richard B⋅Horenstein, R. B.⋅Horenstein, Richard B⋅Horenstein, R.B.⋅Horenstein, R.B.⋅Horenstein, RB⋅Howell, L. A.⋅Howell, Lucius A⋅Howell, Lucius A⋅Howell, Lucius A⋅Howell, L. A.⋅Howell, L.A.⋅Howell, L.A.⋅Howell, L.A.⋅Howell, LA⋅Howell, Lucius A⋅Jeng, Linda J.B⋅Jeng, L.J.B.⋅Jeng, Linda J.B⋅Jeng, Linda J.B⋅Jeng, Linda J.B⋅Jeng, L. J. B.⋅Jeng, LJB⋅Jeng, L.J.B.⋅Jeng, L.J.B.⋅Jeng, L. J. B.⋅Kelemen, M.D.⋅Kelemen, M.D.⋅Kelemen, M.D.⋅Kelemen, M. D.⋅Kelemen, Mark D⋅Kelemen, Mark D⋅Kelemen, Mark D⋅Kelemen, M. D.⋅Kelemen, MD⋅Kelemen, Mark D⋅Lee, Y. M.⋅Lee, YM⋅Lee, Y. M.⋅Lee, Yee Ming⋅Lee, Y.M.⋅Lee, Yee Ming⋅Lee, Y.M.⋅Lee, Yee Ming⋅Lee, Y.M.⋅Magvanjav, Oyunbileg⋅Magvanjav, Oyunbileg⋅Magvanjav, Oyunbileg⋅Magvanjav, O.⋅Magvanjav, O.⋅Magvanjav, O⋅Magvanjav, O.⋅Magvanjav, O.⋅Magvanjav, O.⋅Magvanjav, Oyunbileg⋅Montasser, M.⋅Montasser, M.⋅Montasser, May⋅Montasser, M.⋅Montasser, M.⋅Montasser, May⋅Montasser, M.⋅Montasser, M⋅Montasser, May⋅Montasser, May⋅Nelson, D.R.⋅Nelson, David R⋅Nelson, D. R.⋅Nelson, David R⋅Nelson, D. R.⋅Nelson, David R⋅Nelson, DR⋅Nelson, D.R.⋅Nelson, D.R.⋅Nelson, David R⋅Nutescu, E.A.⋅Nutescu, E.A.⋅Nutescu, EA⋅Nutescu, E. A.⋅Nutescu, Edith A⋅Nutescu, E.A.⋅Nutescu, Edith A⋅Nutescu, Edith A⋅Nutescu, Edith A⋅Nutescu, E. A.⋅Nwaba, D.C.⋅Nwaba, Devon C⋅Nwaba, DC⋅Nwaba, D. C.⋅Nwaba, D.C.⋅Nwaba, Devon C⋅Nwaba, Devon C⋅Nwaba, Devon C⋅Nwaba, D. C.⋅Nwaba, D.C.⋅Pakyz, Ruth E⋅Pakyz, R.E.⋅Pakyz, R.E.⋅Pakyz, R. E.⋅Pakyz, Ruth E⋅Pakyz, Ruth E⋅Pakyz, RE⋅Pakyz, R. E.⋅Pakyz, R.E.⋅Pakyz, Ruth E⋅Palmer, Kathleen⋅Palmer, Kathleen⋅Palmer, K.⋅Palmer, Kathleen⋅Palmer, K.⋅Palmer, K.⋅Palmer, K⋅Palmer, K.⋅Palmer, K.⋅Palmer, Kathleen⋅Peterson, Josh F⋅Peterson, J. F.⋅Peterson, Josh F⋅Peterson, Josh F⋅Peterson, Josh F⋅Peterson, J.F.⋅Peterson, J.F.⋅Peterson, J. F.⋅Peterson, J.F.⋅Peterson, JF⋅Pollin, T.I.⋅Pollin, T. I.⋅Pollin, Toni I⋅Pollin, Toni I⋅Pollin, Toni I⋅Pollin, T.I.⋅Pollin, T.I.⋅Pollin, TI⋅Pollin, T. I.⋅Pollin, Toni I⋅Quinn, Alison H⋅Quinn, A. H.⋅Quinn, Alison H⋅Quinn, AH⋅Quinn, A.H.⋅Quinn, A.H.⋅Quinn, Alison H⋅Quinn, A.H.⋅Quinn, A. H.⋅Quinn, Alison H⋅Robinson, S. W.⋅Robinson, S.W.⋅Robinson, Shawn W⋅Robinson, Shawn W⋅Robinson, SW⋅Robinson, Shawn W⋅Robinson, S.W.⋅Robinson, S.W.⋅Robinson, Shawn W⋅Robinson, S. W.⋅Schub, J.⋅Schub, J.⋅Schub, J.⋅Schub, Jamie⋅Schub, Jamie⋅Schub, Jamie⋅Schub, J.⋅Schub, J⋅Schub, J.⋅Schub, Jamie⋅Skaar, Todd C⋅Skaar, TC⋅Skaar, Todd C⋅Skaar, T.C.⋅Skaar, Todd C⋅Skaar, T. C.⋅Skaar, Todd C⋅Skaar, T. C.⋅Skaar, T.C.⋅Skaar, T.C.⋅Smith, D.M.⋅Smith, D.M.⋅Smith, D. Max⋅Smith, D. Max⋅Smith, D. M.⋅Smith, D. M.⋅Smith, D. Max⋅Smith, DM⋅Smith, D. Max⋅Smith, D.M.⋅Sriramoju, V. B.⋅Sriramoju, V.B.⋅Sriramoju, Vindhya B⋅Sriramoju, V.B.⋅Sriramoju, VB⋅Sriramoju, V.B.⋅Sriramoju, Vindhya B⋅Sriramoju, V. B.⋅Sriramoju, Vindhya B⋅Sriramoju, Vindhya B⋅Starostik, P.⋅Starostik, P.⋅Starostik, Petr⋅Starostik, Petr⋅Starostik, P.⋅Starostik, Petr⋅Starostik, P.⋅Starostik, P.⋅Starostik, P⋅Starostik, Petr⋅Stys, T. P.⋅Stys, T.P.⋅Stys, TP⋅Stys, T.P.⋅Stys, T. P.⋅Stys, Tomasz P⋅Stys, Tomasz P⋅Stys, Tomasz P⋅Stys, T.P.⋅Stys, Tomasz P⋅Stevenson, J.M.⋅Stevenson, J.M.⋅Stevenson, J.M.⋅Stevenson, James M⋅Stevenson, James M⋅Stevenson, J. M.⋅Stevenson, James M⋅Stevenson, J. M.⋅Stevenson, JM⋅Stevenson, James M⋅Varunok, N.⋅Varunok, Nicholas⋅Varunok, Nicholas⋅Varunok, Nicholas⋅Varunok, N.⋅Varunok, N.⋅Varunok, N.⋅Varunok, N.⋅Varunok, N⋅Varunok, Nicholas⋅Vesely, M. R.⋅Vesely, Mark R⋅Vesely, Mark R⋅Vesely, M. R.⋅Vesely, Mark R⋅Vesely, M.R.⋅Vesely, MR⋅Vesely, M.R.⋅Vesely, M.R.⋅Vesely, Mark R⋅Wake, D.T.⋅Wake, Dyson T⋅Wake, Dyson T⋅Wake, DT⋅Wake, Dyson T⋅Wake, Dyson T⋅Wake, D. T.⋅Wake, D.T.⋅Wake, D. T.⋅Wake, D.T.⋅Weck, Karen E⋅Weck, Karen E⋅Weck, K. E.⋅Weck, Karen E⋅Weck, KE⋅Weck, K.E.⋅Weck, K. E.⋅Weck, Karen E⋅Weck, K.E.⋅Weck, K.E.⋅Weitzel, K.W.⋅Weitzel, K.W.⋅Weitzel, Kristin W⋅Weitzel, K. W.⋅Weitzel, Kristin W⋅Weitzel, Kristin W⋅Weitzel, K.W.⋅Weitzel, Kristin W⋅Weitzel, K. W.⋅Weitzel, KW⋅Wilke, R.A.⋅Wilke, RA⋅Wilke, Russell A⋅Wilke, R. A.⋅Wilke, Russell A⋅Wilke, R.A.⋅Wilke, Russell A⋅Wilke, Russell A⋅Wilke, R.A.⋅Wilke, R. A.⋅Willig, J.⋅Willig, J.⋅Willig, J⋅Willig, J.⋅Willig, James⋅Willig, J.⋅Willig, James⋅Willig, James⋅Willig, James⋅Willig, J.⋅Zhao, Richard Y⋅Zhao, R.Y.⋅Zhao, R.Y.⋅Zhao, Richard Y⋅Zhao, Richard Y⋅Zhao, Richard Y⋅Zhao, R. Y.⋅Zhao, RY⋅Zhao, R. Y.⋅Zhao, R.Y.⋅Kreutz, Rolf P⋅Kreutz, R.P.⋅Kreutz, R.P.⋅Kreutz, R.P.⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, RP⋅Kreutz, R. P.⋅Kreutz, R. P.⋅Stouffer, GA⋅Stouffer, G.A.⋅Stouffer, George A⋅Stouffer, G. A.⋅Stouffer, George A⋅Stouffer, G. A.⋅Stouffer, George A⋅Stouffer, G.A.⋅Stouffer, G.A.⋅Stouffer, George A⋅Empey, Philip E⋅Empey, P.E.⋅Empey, P.E.⋅Empey, Philip E⋅Empey, PE⋅Empey, P. E.⋅Empey, P.E.⋅Empey, Philip E⋅Empey, Philip E⋅Empey, P. E.⋅Limdi, Nita A⋅Limdi, N.A.⋅Limdi, N.A.⋅Limdi, Nita A⋅Limdi, Nita A⋅Limdi, Nita A⋅Limdi, N. A.⋅Limdi, NA⋅Limdi, N. A.⋅Limdi, N.A.⋅Shuldiner, A.R.⋅Shuldiner, AR⋅Shuldiner, A.R.⋅Shuldiner, A. R.⋅Shuldiner, Alan R⋅Shuldiner, Alan R⋅Shuldiner, Alan R⋅Shuldiner, A.R.⋅Shuldiner, A. R.⋅Shuldiner, Alan R⋅Winterstein, A. G.⋅Winterstein, A. G.⋅Winterstein, A.G.⋅Winterstein, Almut G⋅Winterstein, Almut G⋅Winterstein, Almut G⋅Winterstein, A.G.⋅Winterstein, A.G.⋅Winterstein, AG⋅Winterstein, Almut G⋅Johnson, J. A.⋅Johnson, J.A.⋅Johnson, Julie A⋅Johnson, Julie A⋅Johnson, J.A.⋅Johnson, JA⋅Johnson, Julie A⋅Johnson, J.A.⋅Johnson, Julie A⋅Johnson, J. A.⋅Network, IGNITE and Network, IGNITEJACC: Cardiovascular Interventions, vol. 11, (no. 2), pp. 191, 2018-01-22.
| Journal Article
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet TherapyEmpey, P.E.⋅Empey, P.E.⋅Empey, Philip E⋅Empey, P.E.⋅Empey, Philip E⋅Empey, Philip E⋅Stevenson, James M⋅Stevenson, J.M.⋅Stevenson, J.M.⋅Stevenson, J.M.⋅Stevenson, James M⋅Stevenson, James M⋅Tuteja, Sony⋅Tuteja, S.⋅Tuteja, Sony⋅Tuteja, S.⋅Tuteja, S.⋅Tuteja, Sony⋅Weitzel, Kristin W⋅Weitzel, Kristin W⋅Weitzel, K.W.⋅Weitzel, K.W.⋅Weitzel, K.W.⋅Weitzel, Kristin W⋅Angiolillo, Dominick J⋅Angiolillo, D.J.⋅Angiolillo, Dominick J⋅Angiolillo, Dominick J⋅Angiolillo, D.J.⋅Angiolillo, D.J.⋅Beitelshees, Amber L⋅Beitelshees, Amber L⋅Beitelshees, A.L.⋅Beitelshees, A.L.⋅Beitelshees, Amber L⋅Beitelshees, A.L.⋅Coons, J.C.⋅Coons, James C⋅Coons, J.C.⋅Coons, James C⋅Coons, James C⋅Coons, J.C.⋅Duarte, J.D.⋅Duarte, Julio D⋅Duarte, J.D.⋅Duarte, Julio D⋅Duarte, J.D.⋅Duarte, Julio D⋅Franchi, Francesco⋅Franchi, F.⋅Franchi, Francesco⋅Franchi, F.⋅Franchi, F.⋅Franchi, Francesco⋅Jeng, L.J.B.⋅Jeng, L.J.B.⋅Jeng, L.J.B.⋅Jeng, Linda J.B⋅Jeng, Linda J.B⋅Jeng, Linda J.B⋅Johnson, J.A.⋅Johnson, Julie A⋅Johnson, Julie A⋅Johnson, J.A.⋅Johnson, J.A.⋅Johnson, Julie A⋅Kreutz, R.P.⋅Kreutz, R.P.⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, R.P.⋅Limdi, N.A.⋅Limdi, Nita A⋅Limdi, Nita A⋅Limdi, Nita A⋅Limdi, N.A.⋅Limdi, N.A.⋅Maloney, Kristin A⋅Maloney, Kristin A⋅Maloney, Kristin A⋅Maloney, K.A.⋅Maloney, K.A.⋅Maloney, K.A.⋅Owusu Obeng, A.⋅Owusu Obeng, Aniwaa⋅Owusu Obeng, Aniwaa⋅Owusu Obeng, A.⋅Owusu Obeng, Aniwaa⋅Owusu Obeng, A.⋅Peterson, J.F.⋅Peterson, J.F.⋅Peterson, Josh F⋅Peterson, J.F.⋅Peterson, Josh F⋅Peterson, Josh F⋅Petry, N.⋅Petry, Natasha⋅Petry, Natasha⋅Petry, N.⋅Petry, N.⋅Petry, Natasha⋅Pratt, V.M.⋅Pratt, Victoria M⋅Pratt, V.M.⋅Pratt, Victoria M⋅Pratt, Victoria M⋅Pratt, V.M.⋅Rollini, F.⋅Rollini, Fabiana⋅Rollini, F.⋅Rollini, Fabiana⋅Rollini, Fabiana⋅Rollini, F.⋅Scott, Stuart A⋅Scott, S.A.⋅Scott, S.A.⋅Scott, Stuart A⋅Scott, Stuart A⋅Scott, S.A.⋅Skaar, T.C.⋅Skaar, Todd C⋅Skaar, T.C.⋅Skaar, T.C.⋅Skaar, Todd C⋅Skaar, Todd C⋅Vesely, M.R.⋅Vesely, M.R.⋅Vesely, Mark R⋅Vesely, M.R.⋅Vesely, Mark R⋅Vesely, Mark R⋅Stouffer, G.A.⋅Stouffer, George A⋅Stouffer, George A⋅Stouffer, G.A.⋅Stouffer, George A⋅Stouffer, G.A.⋅Wilke, R.A.⋅Wilke, R.A.⋅Wilke, Russell A⋅Wilke, R.A.⋅Wilke, Russell A⋅Wilke, Russell A⋅Cavallari, Larisa H⋅Cavallari, Larisa H⋅Cavallari, L.H.⋅Cavallari, L.H.⋅Cavallari, L.H.⋅Cavallari, Larisa H⋅Lee, C.R.⋅Lee, C.R.⋅Lee, C.R.⋅Lee, Craig R⋅Lee, Craig R and Lee, Craig RClinical Pharmacology & Therapeutics, vol. 104, (no. 4), pp. 674, October 2018.
| Journal Article
Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.Kanuri, Sri H⋅Kanuri, Sri H⋅Ipe, Joseph⋅Ipe, Joseph⋅Kassab, Kameel⋅Kassab, Kameel⋅Gao, Hongyu⋅Gao, Hongyu⋅Liu, Yunlong⋅Liu, Yunlong⋅Skaar, Todd C⋅Skaar, Todd C⋅Kreutz, Rolf P and Kreutz, Rolf PAtherosclerosis, vol. 278, pp. 232-239, October 3, 2018.
| Journal Article
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa ActivityKreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Kanuri, Sri⋅Kanuri, Sri⋅Kanuri, Sri⋅Kanuri, Sri⋅Kanuri, Sri⋅Owens, Janelle⋅Owens, Janelle⋅Owens, Janelle⋅Owens, Janelle⋅Owens, Janelle⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅von der Lohe, Elisabeth⋅von der Lohe, Elisabeth⋅von der Lohe, Elisabeth⋅von der Lohe, Elisabeth⋅Von Der Lohe, Elisabeth⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Breall, Jeffrey A and Breall, Jeffrey ATH Open, vol. 2, (no. 2), pp. e181, 20180400.
| Journal Article
2017
Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson.Berlacher, Mark⋅Berlacher, Mark⋅Berlacher, Mark⋅Mastouri, Ronald⋅Mastouri, Ronald⋅Mastouri, Ronald⋅Philips, Santosh⋅Philips, Santosh⋅Philips, Santosh⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Kreutz, Rolf P⋅Kreutz, Rolf P and Kreutz, Rolf PPharmacogenomics, March 30, 2017.
| Journal Article
2016
Fibrin clot strength measured by thromb-elastography and outcomes after percutaneous coronary interventionKreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Schmeisser, Glen⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Maatman, Benjamin⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Schaffter, Andrea⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Von Der Lohe, Elisabeth⋅Von Lohe, Elisabeth⋅Von Lohe, Elisabeth⋅Von Lohe, Elisabeth⋅Von Lohe, Elisabeth⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Breall, Jeffrey A and Breall, Jeffrey AThrombosis and haemostasis, vol. 117, (no. 2), pp. 428, 2016-11-03.
| Journal Article
Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.Kreutz, Rolf P⋅Schmeisser, Glen⋅Maatman, Benjamin⋅Schaffter, Andrea⋅Sinha, Anjan⋅von der Lohe, Elisabeth and Breall, Jeffrey AThrombosis and haemostasis, November 3, 2016.
| Journal Article
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.Eadon, M T⋅Desta, Z⋅Levy, K D⋅Decker, B S⋅Pierson, R C⋅Pratt, V M⋅Callaghan, J T⋅Rosenman, M B⋅Carpenter, J S⋅Holmes, A M⋅McDonald, C A⋅Benson, E A⋅Patil, A S⋅Vuppalanchi, R⋅Gufford, B T⋅Dave, N⋅Robarge, J D⋅Hyder, M A⋅Haas, D M⋅Kreutz, R P⋅Dexter, P R⋅Skaar, T C and Flockhart, D AClinical pharmacology and therapeutics, vol. 100, (no. 1), pp. 63-66, July 2016.
| Journal Article
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.Kreutz, Rolf P⋅Kreutz, Rolf P⋅Kreutz, Rolf P⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Breall, Jeffrey A⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅von der Lohe, Elisabeth⋅von der Lohe, Elisabeth⋅Von Der Lohe, Elisabeth⋅Kovacs, Richard J⋅Kovacs, Richard J⋅Kovacs, Richard J⋅Flockhart, David A⋅Flockhart, David A and Flockhart, David AClinical pharmacology : advances and applications, vol. 8, pp. 45-50, 2016.
| Journal Article
2015
AMPD1 polymorphism and response to regadenoson.Saab, Rayan⋅Saab, Rayan⋅Zouk, Aline N⋅Zouk, Aline N⋅Mastouri, Ronald⋅Mastouri, Ronald⋅Skaar, Todd C⋅Skaar, Todd C⋅Philips, Santosh⋅Philips, Santosh⋅Kreutz, Rolf P and Kreutz, Rolf PPharmacogenomics, vol. 16, (no. 16), pp. 1807-1815, November 2015.
| Journal Article
Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson.Bitar, Abbas⋅Mastouri, Ronald and Kreutz, Rolf PPloS one, vol. 10, (no. 6), pp. e0130487, 2015.
| Journal Article
Platelet activation and pneumonia: is soluble p-selectin the right marker?Gurbel, Paul A⋅Kreutz, Rolf P⋅Bliden, Kevin P and Tantry, Udaya S(pp. 1492-1493). April 14, 2015
Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.Kreutz, Rolf P⋅Owens, Janelle⋅Lu, Deshun⋅Nystrom, Perry⋅Jin, Yan⋅Kreutz, Yvonne⋅Desta, Zeruesenay and Flockhart, David APlatelets, vol. 26, (no. 4), pp. 358-363, 2015.
| Journal Article
Variations in Clinical Presentation, Risk Factors, Treatment, and Prognosis of Spontaneous Coronary Artery Dissection.
Sultan, Adnan and Kreutz, Rolf P
The Journal of invasive cardiology, vol. 27, (no. 8), pp. 363-369, August 2015. | Journal Article
2014
ADENOSINE MONOPHOPHATE DEAMINASE-1 (AMPD1) DEFICIENCY AND RESPONSE TO REGADENOSONKreutz, Rolf⋅Kreutz, Rolf⋅Saab, Rayan⋅Saab, Rayan⋅Mastouri, Ronald and Mastouri, RonaldJournal of the American College of Cardiology, vol. 63, (no. 12), pp. A1113, 2014-04-01.
| Journal Article
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.Kreutz, Rolf⋅Kreutz, Rolf⋅Kreutz, Rolf P⋅Bitar, Abbas⋅Bitar, Abbas⋅Bitar, Abbas⋅Owens, Janelle⋅Owens, Janelle⋅Owens, Janelle⋅Desta, Zeruesenay⋅Desta, Zeruesenay⋅Desta, Zeruesenay⋅Breall, Jeffrey A⋅Breall, Jeffrey⋅Breall, Jeffrey⋅von der Lohe, Elisabeth⋅Von Der Lohe, Elisabeth⋅von der Lohe, Elisabeth⋅Sinha, Anjan⋅Sinha, Anjan⋅Sinha, Anjan⋅Vatta, Matteo⋅Vatta, Matteo⋅Vatta, Matteo⋅Nystrom, Perry⋅Nystrom, Perry⋅Nystrom, Perry⋅Jin, Yan⋅Jin, Yan⋅Jin, Yan⋅Flockhart, David⋅Flockhart, David and Flockhart, David AJournal of thrombosis and thrombolysis, vol. 38, (no. 3), pp. 380-387, October 2014.
| Journal Article